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Abstract
Proteasomes are essential components of the cellular protein degradation machinery. They are nonlysosomal and their
participation is critical for (1) the removal of short lived proteins involved in metabolic regulation and cell proliferation, (2)
the control of the activities of regulators involved in gene transcription, such as nuclear factor-UB (NF-UB) and signal
transducer and activator of transcription (STAT1), and (3) processing of antigenic peptides for MHC class I presentation.
Trauma-hemorrhage induces profound immunosuppression which is characterized by reduced splenocyte proliferation,
interleukin (IL)-2 and interferon (IFN)-Q productive capacity, increased activation of transcription factors NF-UB and
STAT1 in splenic T lymphocytes, reduced macrophage antigen presentation capacity and inordinate release of
proinflammatory cytokines, such as IL-6 and tumor necrosis factor-K. Furthermore, it appears that the activity of several
regulatory proteins involved in immune function is altered by trauma-hemorrhage. Since proteasomes are involved in
regulation and removal of regulatory proteins, we hypothesized that trauma-hemorrhage alters proteasomal activity in
splenic lymphocytes. The data showed that activities of 26s proteasome from CD3CD4 and CD3CD8 splenic T
lymphocytes were enhanced following trauma-hemorrhage which was associated with increased expression of NF-UB and
STAT1. On the other hand, trauma-hemorrhage attenuated the activity of 26s proteasome from splenic B lymphocytes which
was restored upon IFN-Q stimulation and correlated with increased expression of NF-UB. These studies indicate a potential
role for proteasomes in the regulation of signal transduction in splenic T and B lymphocytes following trauma-hemorrhage,
and also suggest them as potential therapeutic targets for attenuation of immune suppression associated with this form of
injury. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Proteasomes are high-molecular-mass multi-cata-
lytic ATP-dependent regulatory proteases. They are
nonlysosomal and are present in the cytoplasm and
nucleus as a hetero-oligomeric complex with an ap-
parent sedimentation coe⁄cient of 26s [1,2]. Proteo-
lytic degradation of proteins with proteasomes oc-
curs in the presence or absence of ubiquitin [3^5]
and is responsible for the selective removal of un-
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necessary proteins, such as abnormal proteins gener-
ated in the cells, transcription factors with rapid
turnover rates, and key proteins that are closely re-
lated to cell cycle progression and metabolic regula-
tion [1,2,6]. Proteasomes are also involved in the ac-
tivation of transcription factor, nuclear factor UB
(NF-UB). The genes regulated by NF-UB include
those involved in immune responses such as hemato-
poietic growth factors, chemokines and leukocyte ad-
hesion molecules [7]. The most common form of NF-
UB is a heterodimer composed of a p50 and a p65
(also termed as Rel A) proteins [8,9]. Proteolysis
mediated by ubiquitinated proteasomes are required
for the activation of NF-UB and its release into the
nucleus. The p105, precursor of the p50 subunit of
NF-UB, is processed by ubiquitin-mediated protea-
some in the presence of ATP. The NF-UB hetero-
dimer, p65^p50, is present in the cytoplasm as a ter-
nary complex with the inhibitory protein IUB.
Phosphorylation of IUB with a speci¢c kinase [10^
12] and subsequent proteolysis mediated by protea-
some are essential for the release of NF-UB [13] and
translocation into nucleus for interaction with specif-
ic response elements involved in gene activation.
Similarly, proteasomal processing has been reported
to be essential for the negative regulation of signal
transducer and activator of transcription (STAT1),
another transcription factor which is also involved
in cytokine gene activation [14]. Furthermore, pro-
teasomes are also implicated in antigen processing
since the genes coding for two nonessential protea-
some subunits are located within the major histo-
compatibility complex (MHC) class II region [15^
18] and these genes are inducible by interferon
(IFN)-Q for augmented incorporation into proteaso-
mal catalytic components [19^21]. Thus, proteasomes
appear to have three important regulatory functions:
(i) the removal of short-lived proteins, (ii) activation
and regulation of transcription factors involved in
gene activity, and (iii) processing of antigens for
MHCI presentation.
A number of studies have shown that following
trauma-hemorrhagic injury there is profound im-
mune depression [22,23]. Furthermore, the immuno-
depression following trauma-hemorrhage is linked to
derangement of immune cell functions, including
splenocytes, observed by depressed mitogenic re-
sponses, altered release and activity of cytokines,
and decreased antigen presenting capacity by macro-
phages. In a recent study [24], we have observed an
enhancement of receptor-initiated phosphorylation
and activation of transcription factors, STAT1 and
NF-UB, following trauma-hemorrhage in murine
splenic T lymphocytes. Activation of these signals
was further augmented by IFN-Q. Proin£ammatory
cytokines released by splenocytes following trauma-
hemorrhage appeared to mediate the activation of
these signals in T lymphocytes. Proteasomes, may
have an exigent role in hemorrhagic shock because
of their involvement in the regulation of transcrip-
tion factors, NF-UB [13] and STAT1 [14] and in anti-
gen processing [25]. Increased expressions of NF-UB
and STAT1 in splenic T lymphocytes [24] and de-
pression in macrophage antigen presentation [26] fol-
lowing trauma-hemorrhage prompted us to evaluate
the activity of 26s proteasome in splenic T and B
lymphocytes. Although, involvement of proteasomes
has been observed in T-lymphocyte activation and
proliferation [27] and in the processing of antigens
for MHCI presentation by B lymphocytes [4,25],
there is very little information available concerning
proteasomal activity in vivo and regulation of NF-
UB and STAT1 expressions in splenic T and B lym-
phocytes following trauma-hemorrhagic shock. This
information is essential since T- and B-lymphocyte
functions are compromised following trauma-hemor-
rhage, and modulation of proteasomal activity may
restore their functions. The present study shows aug-
mentation in the activity of 26s proteasomes in the
T-lymphocyte CD3CD4 and CD3CD8 subsets
following trauma-hemorrhage. Activation of the
CD3CD8 subset correlated with activation of
JAK1, STAT1 and NF-UB expressions and, func-
tionally, at the level of cytolytic activity. In B lym-
phocytes, increased activity of 26s proteasome was
associated with increased NF-UB expression in
sham as well as trauma-hemorrhaged mice following
IFN-Q stimulation.
2. Materials and methods
2.1. Materials, antibodies and bu¡ers
All reagents were of analytical grade. The antibod-
ies used were: monoclonal antibodies to JAK1 and
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STAT1 (Transduction Laboratories, Lexington,
KY); rabbit polyclonal antiNF-UBp65 and alkaline
phosphatase-conjugated antirabbit goat antibody
(Rockland, Gilbertsville, PA); alkaline phosphatase
conjugated goat antibody to mouse IgG2, £uorescein
isothiocyanate (FITC)-conjugated antiCD3, phycoer-
ythrin (PE)-conjugated antiCD4, Cy-chrome (Cyc)-
conjugated antiCD8 and Cyc-conjugated antiB220
(PharMingen, La Jolla, CA). Recombinant mouse
IFN-Q was obtained from RpD Systems, Minneap-
olis, MN. Na512 CrO4 (speci¢c activity 512 mCi/mg)
was purchased from NEN Life Sciences, Boston,
MA. Hexokinase, glucose, ATP, Boc-Leu-Arg-Arg-
AMC, Suc-Leu-Leu-Val-Tyr-AMC and Cbz-Leu-
Leu-Glu-LNA were obtained from Sigma, St Louis,
MO. Lactacystin was from Calbiochem, La Jolla,
CA and Tyr-Gly-Arg-CH2Cl was custom synthe-
sized. YAC-1 Cells (American Type Culture Collec-
tion, Rockville, MD) were grown and maintained in
our tissue culture laboratory according to the suppli-
er’s speci¢cation.
2.2. Animals
Inbred C3H/HEN male mice, 6^8 weeks old and
weighing 20^25 g, were purchased from Charles Riv-
er Laboratories, Wilmington, MA. Animal studies
were conducted in accordance with the guidelines
set by National Institutes of Health and the proto-
cols were approved by the Rhode Island Hospital
Institutional Animal Care and Use Committee. The
procedures for inducing trauma (laparotomy)-hemor-
rhage have been described in detail in earlier publi-
cations [24,28]. The mice were randomly assigned to
two groups (n = 3^4 per group). In sham-operated
control the mice underwent same anesthetic and sur-
gical procedures, but hemorrhage and resuscitation
were not carried out. In experimental animals trauma
was induced by a 2-cm ventral midline laparotomy,
followed by hemorrhage consisting of blood with-
drawal to 30 mmHg arterial pressure which was
maintained for 90 min. The animals were resuscitated
with 4U (volume of blood drawn) Ringer’s lactate
bu¡er. Pools of 3^4 mice were used in each experi-
ment, and each experiment was performed a mini-
mum of three times.
2.3. Splenocyte preparation and enrichment of
T-lymphocyte subsets and B lymphocytes
The procedure for the preparation of splenocytes
is described in an earlier publication [24]. Enrichment
of T cells was accomplished by passing the spleno-
cyte suspension through nylon wool column packed
to 10 ml in 20-ml syringes. Enriched T-cell prepara-
tion which consisted of both CD3CD4 and
CD3CD8 subsets was further fractionated by
high negative selection chromatography using murine
T-cell CD4 subset and CD8 subset column kits
(RpD Systems) according to the procedure given
by the manufacturer. The panning procedure of
Mage [29] using antimouse Ig antibody coated petri
dishes was followed for the enrichment of Ig-positive
B lymphocytes from the splenocyte preparation.
2.4. Flow cytometric analysis
To determine the percentage of CD3CD4 and
CD3CD8 cells in T-lymphocyte subset prepara-
tions and B220 cells in the B-lymphocyte prepara-
tion, cells were stained with a combination of anti-
bodies conjugated to FITC, PE and Cyc for cell
sorting and £ow cytometric analysis. In a typical ex-
periment, 2U106 cells were incubated with 10 Wg/ml
of nonspeci¢c mouse IgG in PBS containing 1% bo-
vine serum albumin and 0.1% sodium azide (PAS)
for 15 min on ice. The cells were washed by centri-
fugation and incubated with 25 Wl of PAS solution
containing 1 Wg of monoclonal antibodies against
CD4 (PE-conjugated), CD8 (Cyc-conjugated) and
CD3 (FITC-conjugated) for T cells and B220 (Cyc-
conjugated) for B cells. The cells were washed with
PBS and ¢xed with 1% paraformaldehyde in PBS
(pH 7.4) for 30 min. After ¢xation cells were pelleted
by centrifugation and resuspended in 1 ml of PBS,
and stored in the dark at 4‡C until cyto£uorometric
analysis. Isotypic controls consisting of 1 Wg of either
FITC, PE, Cyc-conjugated rat IgG2 or FITC-conju-
gated hamster Ig per 106 cells were incubated in the
experiment for assessment of non-antibody staining.
The multicolor £ow cytometric analysis was carried
out in a 70S spectrum laser (Spectrum Products Di-
vision, Palo Alto, CA) operated FACSort (Becton
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Dickinson, Palo Alto, CA) instrument. FITC, PE
and Cyc conjugates were excited with argon laser
at 488 nm and detected at respective emissions at
530 þ 15, 575 þ 15 and 670 nm. Emission overlaps
were corrected by electronic compensation.
2.5. Proteasome preparation
Proteasomes (26s) were prepared from enriched
CD3CD4 and CD3CD8 T-lymphocyte subsets
and B lymphocytes using the procedure described by
Reidlinger et al. [30]. Brie£y, 5^10U107 cells were
homogenized in 10 ml of bu¡er A (20 mM Tris^
HCl (pH 7.0) containing 5 mM ATP, 1 mM L-mer-
captoethanol, 0.1 mM EDTA and 20% glycerol).
After removal of cell debris from the homogenate
by centrifugation at 10 000Ug for 60 min, the 26s
proteasome was sedimented by centrifugation at
140 000Ug for 6 h. The pellet was resuspended in
bu¡er A and adsorbed to 10 ml of hydroxyl apatite
(Biogel) equilibrated in bu¡er A for 1 h at 4‡C. Un-
bound proteins were recovered by centrifugation,
concentrated with Amicon XM50 membranes (Ami-
con, Lexington, MA) and layered on six discontinu-
ous gradients of sucrose (10^30% sucrose in bu¡er A
without glycerol), and centrifuged at 115 000Ug for
16 h. The fractions containing the protease activity
were pooled, concentrated again on Amicon XM50
membrane and applied to a Sepharose-6 gel ¢ltration
column (Pharmacal 16/50 equilibrated with 20 mM
Tris^HCl (pH 7.5) containing 2 mM ATP, 1 mM
mercaptoethanol, 100 mM NaCl and 10% glycerol),
and chromatographed with the equilibration bu¡er.
Fractions containing the protease activity were
pooled, dialyzed against bu¡er A containing 1 mM
dithiothreitol instead of mercaptoethanol, concen-
trated with the Amicon XM membrane and stored
at 320‡C. The protein content of the preparation
was determined by £uorometric assay using NanO-
range (Molecular Probes, Eugene, OR). The protease
activity of the fractions obtained at di¡erent steps of
the preparative procedure was monitored by £uoro-
metric assay using the synthetic substrate, Boc-Leu-
Arg-Arg-AMC as described below.
2.6. Enzyme assays
Peptidase activities were assayed with synthetic
substrates dissolved in 50 mM Hepes bu¡er, pH
7.5 or 8.0 [31]. Trypsin-like activity was assayed
with Boc-Leu-Arg-Arg-AMC, chymotrypsin-like ac-
tivity with Suc-Leu-Leu-Val-Tyr-AMC and peptidyl-
glutamyl peptidase activity with Cbz-Leu-Leu-Glu-
LNA. The assays were carried out in 250-Wl reaction
mixtures in 96-well microtiter plates (Corning, Corn-
ing, NY), and £uorescence measurements were made
on a Bio-Tek FL500 Plate reader (Bio-Tek Instru-
ments, Winooski, VT) at 395 nm (excitation) and
495 nm (emission). Inhibition of the protease activity
was determined by assaying peptidase activity after
preincubation of the enzyme with the inhibitors for
30 min at 25‡C. SigmaPlot and SigmaStat softwares
(Jandel, San Rafael, CA) were used for nonlinear
regression analysis of data. The hyperbolic equation,
f = a*x/(b+x) was used for calculating maximal ve-
locity, Vmax, and Km of the proteasome.
2.7. JAK1, STAT1 and NF-UB expressions
The procedure of Imbert et al. [32] was followed
for preparation of cell lysate needed for determining
JAK1 and STAT1 expressions and Dignan et al. [33]
for the preparation of nuclear extracts for NF-UB
analysis. Since, NF-UB is released from its ternary
complex with IUB in the cytoplasm and is immedi-
ately translocated into the nucleus (especially after
stimulation), its analysis in nuclear extracts will be
synonymous with its activation. NF-UB expression
was determined by two separate procedures: assay
for transcriptional activity by Western blot analysis
and for DNA binding by electrophoretic mobility
shift assay. Monoclonal antibodies to JAK1 and
STAT1 and polyclonal rabbit antiNF-UBp65 were
used, respectively for probing JAK1, STAT1 and
NF-UB on the immunoblots. The procedures for im-
munoprecipitation, electrophoresis, Western blot
transfer and probing of bands with antisera are de-
scribed in an earlier publication [24]. The images for
typical blots were captured using a MOCHA II im-
age analysis work station (Jandel Scienti¢c, San Ra-
fael, CA).
2.8. Electrophoretic mobility shift assay
The procedures for NF-UB probe preparation, its
labeling with [Q-32P]ATP, binding reaction and elec-
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trophoresis are described elsewhere [24]. The gels
were analyzed for radioactivity in InstantImager
(Packard, Meriden, CT).
2.9. Measurement of cytotoxic T-lymphocyte activity
The ¢rst basic protocol of Wunderlich and Shearer
[34] was followed for induction and detection of cy-
totoxic T-lymphocyte activity. For sensitization of
e¡ector cells, T-cell subsets (106/ml in RPMI-10 com-
plete media) were treated with 0.5 mg/ml mitomycin
C and stimulated in the presence or absence of 10 Wg/
ml concanavalin A (Con A), and cultured for 5 days
in a humidi¢ed 5% CO2 incubator at 37‡C before use
in a 51Cr release assay [34]. Target cells were pre-
pared by incubation of 5 ml of rapidly dividing
YAC-1 cells (1U106/ml) in a complete RPMI media
containing 100 WCi per ml of Na512 CrO4 (NEN Life
Sciences) in a humidi¢ed 5% CO2 incubator for 3 h
at 37‡C. Following incubation the cells were pelleted,
washed three times with media and resuspended in
media at 1U105 cells/ml. The cytotoxicity assay was
carried out in 96-well u-bottom plates (Corning) in
which each well contained 104 51Cr-labeled cells in
100 Wl. Sensitized T cells in complete medium were
added to give e¡ector to target cell ratios of 10:1,
33:1, 100:1, 333:1, 1000:1, 3333:1 and 10000:1 in a
total volume of 200 Wl. After incubation for 5 h at
37‡C in a humidi¢ed 5% CO2 incubator, cell-free
supernatants were collected by centrifuging at
500Ug for 15 min, and 100-Wl aliquots were counted
for radioactivity in a gamma counter (Wallac, Gai-
Fig. 1. Flow cytometric analysis of T-lymphocyte CD3CD4 and CD3CD8 subsets. T-Cell subsets from antiCD4 and antiCD8
columns were reacted with FITC-conjugated-antiCD3, PE-conjugated antiCD4 and Cyc-conjugated antiCD8 antibodies. Multicol-
or analysis of stained cells was assayed by cyto£uorometry. Histograms show that cells from the antiCD8 column (A and B) or
antiCD4 column (C and D) were s 85% CD3CD4 (A and B) or CD3CD8 (C and D), respectively. Sham, A and C; trauma-
hemorrhage, B and D. x-Axis, FITC-antiCD3, emission 525 nm; y-axis, PE-antiCD4, emission 575 nm and Cyc-antiCD8, emission
670 nm.
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thersburg, MD). All incubations were carried out in
triplicate. The results are expressed as the ID50 of
e¡ector cells which was calculated from the percent-
age of speci¢c lysis, at di¡erent e¡ector to target cell
ratios, according to the formula: % speci¢c lysis =
(experimental release3spontaneous release)/(max-
imal release3spontaneous release). The spontaneous
release in 3 h was 6 10% of the maximal release
induced by 5% Triton X-100.
2.10. Statistical analysis
SigmaStat, version 2.0 (Jandel, San Rafael, CA),
was used for descriptive statistics, one-way analysis
of variance and complete comparison Student^New-
man^Keuls analyses. Data are expressed as the
mean þ standard deviation. P6 0.05 was considered
signi¢cant.
3. Results
3.1. Purity of T-lymphocyte subset and B-lymphocyte
preparations
The purity of the T-lymphocyte subsets enriched
by chromatography on antiCD4 and antiCD8 col-
umns were determined by multi color cyto£uoromet-
ric analysis using £uorescent-labeled antibodies for
the respective subsets. The data presented in Fig. 1
demonstrate that the T lymphocytes from antiCD8
column were s 85% CD3CD4 and from antiCD4
Fig. 3. The activity (A) and properties (B) of 26s proteasome
prepared from enriched splenic T lymphocytes. The assays were
carried out in a 200 Wl reaction mixture pH (7.5), containing 50
mM Hepes/KOH, 50 WM Boc-Leu-Arg-Arg-AMC, and 1 Wg
proteasome preparation. The proteasome preparation was
treated with the inhibitors (100 WM) for 30 min at 4‡C before
adding to the assay mixture. C, control; H, 5 units/ml of hexo-
kinase+5 mM glucose; H+ATP, hexokinase+glucose+2 mM
ATP; CE, Tyr-Gly-Arg-CH2Cl; LCY, lactacystin. P6 0.05.
Fig. 2. Flow cytometric analysis of B lymphocytes for B220
epitope. Cell suspensions obtained after panning splenocytes on
mouse antiIgG antiserum were reacted with Cyc-conjugated
B220 antibody and analyzed by cyto£uorometry. The histogram
(Cyc-antiB220 £uorescence, emission 670 nm vs. cell size)
shows s 90% were B220. Analysis was similar for B220 lym-
phocyte preparations from sham and trauma-hemorrhaged ani-
mals (data not shown).
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column were s 90% CD3CD8. Cross-contamina-
tion of each lymphocyte subset in sham and trauma-
hemorrhage preparations was less than 15%.
The percentage of B220 cells in the B-lymphocyte
preparation obtained by panning of splenocytes with
antimouse IgG-coated plates was greater than 90%
(Fig. 2). The cyto£uorometric analysis of B-lympho-
cyte preparation, however, indicated heterogeneity in
size distribution due to the presence of granular lym-
phocytes. There were no CD3 cells in the B-lym-
phocyte preparation (data not shown).
3.2. Properties of 26s proteasome prepared from
enriched splenic T lymphocytes
The rate of hydrolysis of Boc-Leu-Arg-Arg-AMC
by proteasome prepared from splenic CD3 T lym-
phocytes is shown in Fig. 3A. The proteasome
preparation showed characteristic Michaelis^Menten
kinetics over a wide range of concentrations of the
substrate with a Vmax of 820 (£uorescence) and a
Km value of 53 WM. Treatment with hexokinase
(5 units/ml) and glucose (5 mM) inhibited s 70%
of the peptidase activity (Fig. 3B). Addition of
2 mM ATP completely restored the activity. The
competitive inhibitor, Tyr-Gly-Arg-CH2Cl (100 WM),
and the microbial peptide, lactacystin (100 WM),
abolished s 90% of the peptidase activity. The
preparation thus displayed properties of a protea-
some and not that of lysosomal peptidase or cyto-
plasmic endonuclease.
3.3. Peptidase activities of 26s proteasomes isolated
from T-lymphocyte subsets of
trauma-hemorrhaged mice
After ascertaining that the 26s proteasome pre-
pared from T lymphocytes exhibited characteristics
typical of a proteasome, properties of proteasomes
prepared from the T-cell subsets were compared.
The trypsin-like, chymotrypsin-like and peptidyl-glu-
tamyl peptidase activities of 26s proteasomes from
the T-lymphocyte subsets of sham and trauma-he-
morrhaged mice are shown in Fig. 4. The proteasome
preparations exhibited kinetics characteristic of reg-
ulatory enzymes. Km values were nearly similar for
all proteasome preparations irrespective of the T-cell
subset, trauma-hemorrhage insult or the substrate.
However, di¡erences were observed in Vmax and the
speci¢c activities (Table 1). CD3CD8 lymphocytes
from sham and trauma-hemorrhage groups exhibited
slightly higher proteasomal activity when compared
to CD3CD4 lymphocytes in trypsin-like and chy-
motrypsin-like activities. Trauma-hemorrhage aug-
Fig. 4. Activities of 26s proteasomes prepared from CD3CD4 and CD3CD8 lymphocytes of sham and trauma-hemorrhage mice.
The assays were carried out in a 200 Wl reaction mixture (pH 7.5), containing 50 mM Hepes/KOH, di¡erent concentrations of syn-
thetic peptide substrates and 1 Wg proteasome preparation. CD3CD4 : sham (F), trauma-hemorrhage (E) ; CD3CD8 : sham (b),
trauma-hemorrhage (a). The error bars represent the standard deviation, n = 3^4.
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mented proteasomal activity in both the subsets
and the CD3CD8 lymphocytes of trauma-hemor-
rhage group appeared to posses the highest level of
activity.
3.4. JAK1, STAT1 and NF-UB expressions in
CD3+CD4+ and CD3+CD8+ subsets following
trauma-hemorrhage
The expression of JAK1, and STAT1 in the cyto-
sol and NF-UB in nuclear extracts of CD3CD4
and CD3CD8 cells from sham and trauma-hemor-
rhaged mice was determined by Western blot analysis
(Fig. 5). Increased expression of all three signals was
observed in the CD3CD8 cells from trauma-
hemorrhaged mice. Conversely, the trauma-hemor-
rhage group showed reduced expression of JAK1
and STAT1 in CD3CD4 lymphocytes compared
to expression in lymphocytes from the sham group.
Increased NF-UB expression, as determined by West-
ern blot appeared to be restricted to the CD3CD8
subset of trauma-hemorrhaged mice (Fig. 5). How-
ever, analysis by electrophoretic mobility shift assay
(Fig. 6) indicated increased NF-UB expression also in
CD3CD4 lymphocytes of trauma-hemorrhaged
mice.
3.5. Cytotoxic activities of CD3+CD4+ and
CD3+CD8+ lymphocytes
Experiments were undertaken to determine
whether trauma-hemorrhage altered the cytotoxic ac-
tivity of the T-cell subsets. The cytotoxic response of
Fig. 5. Western blot analysis of cell lysates from CD3CD4
and CD3CD8 lymphocytes of sham (S) and trauma-hemor-
rhage (TH) mice for JAK1, STAT1 and NF-UB expressions.
Cell lysates were immunoprecipitated with respective antibodies
and adsorbed to protein A Sepharose. The gel pellets, after
washing, were extracted with Laemmli’s sample bu¡er and ali-
quots (5 Wg protein) electrophoresed on SDS^PAGE, trans-
ferred to nylon membranes and probed with respective antibod-
ies. The molecular masses of the protein standards are
indicated with an arrow.
Table 1
Properties of proteasomes from CD3CD4 and CD3CD8 T-cell subsets of sham and trauma-hemorrhaged mice
Km Vmax v
Trypsin-like activity
CD3CD4 Sham 28.5 500 0.56
Trauma-hemorrhage 25.2 780 0.88
CD3CD8 Sham 29.5 580 0.68
Trauma-hemorrhage 23.6 810 0.98
Chymotrypsin-like activity
CD3CD4 Sham 30.2 380 0.48
Trauma-hemorrhage 27.1 623 0.72
CD3CD8 Sham 35.8 420 0.53
Trauma-hemorrhage 22.1 780 1.08
Peptidyl-glutamyl peptidase activity
CD3CD4 Sham 28.2 290 0.36
Trauma-hemorrhage 26.7 383 0.68
CD3CD8 Sham 33.3 259 0.34
Trauma-hemorrhage 24.2 421 0.75
The data on Km (WM), Vmax (£uorescence) and speci¢c activity, v (Wmol substrate cleaved per Wg protein per h) were derived from the
plots in Fig. 4 by nonlinear regression and rectangular hyperbolic function analysis.
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T-cell subsets from sham and trauma-hemorrhaged
animals, against YAC-1 cells, is shown in Fig. 7. The
results showed that although low levels of cytotoxic
activity were observed in non stimulated e¡ector
cells, stimulation with Con A increased the cytotoxic
response. An increased cytotoxic response with Con
A was observed in CD3CD4 cells of both the
sham and trauma-hemorrhage groups. However,
Con A stimulation of CD3CD8 cells greatly in-
creased the cytotoxic response only in cells from
the trauma-hemorrhage group, and this increased cy-
tolytic activity of CD3CD8 cells was the highest
compared to all the other groups.
Fig. 8. Activities of 26s proteasomes prepared from B220 lymphocytes of sham and trauma-hemorrhage mice. The assays were car-
ried out in a 200 Wl reaction mixture (pH 7.5), containing 50 mM Hepes/KOH, di¡erent concentrations of synthetic peptide substrates
and 1 Wg proteasome preparation. B220 lymphocytes were stimulated with (+) or without (3) 100 units/ml of IFN-Q for 1 h at 37‡C.
CD3CD4 : sham (F), sham+IFN-Q (E), trauma-hemorrhage, (b), trauma-hemorrhage+IFN-Q (a). The error bars represent the stand-
ard deviation, n = 3^4.
Fig. 7. Cytotoxic activity of T-lymphocyte subsets. 51Cr-Labeled
YAC1 cells were used as target cells. CD3CD4 and
CD3CD8 cells from sham (S) and trauma+hemorrhage (TH)
mice were sensitized with mitomycin C with (+) or without (3)
Con A prior to mixing with target cells in the 51Cr release as-
say. The e¡ector activity on the y-axis is ID50. The error bars
represent the standard deviation, n = 3^4. P6 0.05.
Fig. 6. NF-UB expression in nuclear extracts of CD3CD4
and CD3CD8 lymphocytes from sham (S) and trauma-hem-
orrhage (TH) mice by electrophoretic mobility shift assay. Ali-
quots containing 5 Wg protein were used in each analysis. The
details of the assay procedure are given in Section 2. C, con-
trol ; A, CD3CD4 cells ; B, CD3CD8 cells.
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3.6. Peptidase activities of 26s proteasomes isolated
from B lymphocytes of trauma-hemorrhaged mice
The peptidase activities of 26s proteasome, on the
basis of Vmax and speci¢c activity, v, was lower in B
lymphocytes (Fig. 8 and Table 2) as compared to T-
cell subsets (Fig. 4 and Table 1). A decrease in the
trypsin-like and chymotrypsin-like activities and an
increase in the peptidyl-glutamyl peptidase activity of
proteasomes was observed in B lymphocytes from
trauma-hemorrhaged animals compared to sham.
IFN-Q treatment of B lymphocytes resulted in an in-
crease of trypsin-like and a decrease of peptidyl-glu-
tamyl peptidase activities in both sham and trauma-
hemorrhage groups. The chymotrypsin-like activity
increased in the trauma-hemorrhage group and not
in the sham group.
3.7. NF-UB expression in B lymphocytes
Expression of NF-UB in nuclear extracts of B lym-
phocytes was determined by Western blot (Fig. 9)
and electrophoretic mobility shift assay (Fig. 10).
The results showed decreased expression of NF-UB
in B lymphocytes from trauma-hemorrhaged ani-
mals. However, stimulation with IFN-Q increased
the NF-UB expression in both the sham and trau-
ma-hemorrhage groups.
4. Discussion
Intracellular proteolysis serves as an important
control mechanism of regulatory proteins, since
they are metabolically labile and rapid changes in
their concentration demand a short half-life. The
number of proteases involved in this process is not
Fig. 10. NF-UB expression in nuclear extracts of B220 lym-
phocytes from sham (S) and trauma-hemorrhage (TH) mice by
electrophoretic mobility shift assay. Aliquots containing 5 Wg
protein were used in the analysis. Stimulation with IFN-Q ( þ )
was carried out by treatment of cells with 100 units/ml for 1 h
at 37‡C.
Fig. 9. Western blot analysis of NF-UB expression in cell lysates
of B220 lymphocytes from sham (S) and trauma-hemorrhage
(TH) mice. The details of the immunoblot procedure are given
in Section 2. Aliquots containing 5 Wg (1U) and 10 Wg (2U)
protein were analyzed. B220cells were stimulated with (+) or
without (3) 100 units/ml of IFN-Q (I) for 1 h at 37‡C.
Table 2
Properties of proteasomes from B220 cells of sham and trau-
ma-hemorrhaged mice
Km Vmax v
Trypsin-like activity
Sham 52.6 235 0.45
Trauma-hemorrhage 58.2 207 0.39
Sham+IFN-Q 44.6 310 0.52
Trauma-hemorrhage+IFN-Q 48.5 371 0.78
Chymotrypsin-like activity
Sham 28.8 155 0.52
Trauma-hemorrhage 24.1 115 0.43
Sham+IFN-Q 26.9 150 0.56
Trauma-hemorrhage+IFN-Q 22.9 237 0.72
Peptidyl-glutamyl peptidase activity
Sham 31.2 190 0.50
Trauma-hemorrhage 28.0 277 0.57
Sham+IFN-Q 33.5 145 0.41
Trauma-hemorrhage+IFN-Q 35.8 158 0.43
The data on Km (WM), Vmax (£uorescence) and speci¢c activity,
v (Wmol substrate cleaved per Wg protein per h) were derived
from the plots in Fig. 8 by nonlinear regression and rectangular
hyperbolic function analysis.
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known and is being examined in many investigations
including the pathological condition emerging from
trauma-hemorrhage where in£ammatory stimuli ac-
celerate the turnover of many regulatory proteins.
Surprisingly, the number of endopeptidases present
in cytoplasm and nucleus are very few compared to
lysosomal cathepsins and the secreted proteases.
However, a number of endoplasmic peptidases have
been identi¢ed, and they include calpain [35], metal-
loproteinase [36], proline endopeptidase [37], several
caspases [38] and the proteasome. The proteasome
cleaves small and large peptides at neutral or slightly
basic pH at the carboxyl side of acidic, basic and
hydrophobic residues. Recent studies have shown
that 20s and 26s proteasomes are involved in the
regulation of activities of many short-lived proteins
involved in signal transduction and in cell division
[5,6]. Participation of proteasomes in the activation
of transcription factors, NF-UB [13] and STAT1 [14],
and in the processing of antigens for MHCI I [25]
presentation has been unequivocally demonstrated.
Hemorrhage, which is normally associated with
trauma, causes a pronounced depression in immune
function subsequent to increased risk of infection
and multiple organ failure [39]. The immunodepres-
sion is induced by severe aberrations in immune cell
activity as evidenced by suppressed T-lymphocyte
activity (reduced interleukin (IL)-2 and IFN-Q re-
lease), increased release of proin£ammatory cyto-
kines IL-6, IL-1L and tumor necrosis factor (TNF)-
K by Kup¡er cells, and reduced antigen presentation
by macrophages [22,23,28]. Motivating factors ap-
pear to be related to perturbations in the signal
transduction mechanisms, such as [Ca2]i immobili-
zation [23,26] and enhancement in the expression of
transcription factors, JAK1, STAT1 and NF-UB [24].
Proteasomes activate NF-UB by proteolysis of IUB
[13], regulate STAT1 activity negatively by proteoly-
sis [14], generate MHCI antigenic peptides by limited
proteolysis [25] or rapidly degrade c-fos and c-jun,
which have very short half-lives, by proteolysis [40].
Based on these observations, proteasome participa-
tion both in the activation, regulation and scaveng-
ing of regulatory proteins in T and B lymphocytes in
response to trauma-hemorrhage is anticipated. Im-
munosuppression results in activation of several reg-
ulatory proteins involved in cell proliferation and
di¡erentiation and their rapid removal is essential
for the maintenance of normal growth and metabo-
lism. Concomitantly, many in£ammatory mediators
are activated by phosphorylation and are degraded
rapidly by proteasomes, as in the case of the critical
inhibitory factor IUB for activation of NF-UB [13].
Recently, Wang et al. [27] have also reported protea-
somes playing a crucial role in T-cell activation and
proliferation through multiple mechanisms. Our ear-
lier study [24] has shown increased expressions of
cytokine-receptor mediated kinase, JAK1 and tran-
scription factors STAT1 and NF-UB in splenic T
lymphocytes following hemorrhage with or without
laparotomy. In this study, we observe that the signal
activations are preferential to the CD3CD8 lym-
phocyte subset. Furthermore, the increase in signal
expressions is accompanied by augmented activities
of 26s proteasome and increased cytotoxicity of the
CD3CD8 subset of trauma-hemorrhaged animals.
Similarly, a link between activities of 26s proteasome
and activation of p65^p50 heterodimer of NF-UB
was evidenced in B lymphocytes. Although p50-c-
Rel is the constitutive heterodimer of NF-UB in B
lymphocytes, p65^p50 heterodimer is also expressed
in the cytoplasm and not in the nucleus [8,41]. Cyto-
kines including IFN-Q can stimulate p65^p50 hetero-
dimer expression in B cells, which is consistent with
our observation. This NF-UB heterodimer expression
was attenuated in B lymphocytes following trauma-
hemorrhage and the expression was restored upon
IFN-Q stimulation. The reason for the decrease in
NF-UB expression in B lymphocytes of trauma-hem-
orrhaged mice is not clear, although the contribu-
tion of elevated circulatory levels of TNF-K observed
following trauma-hemorrhage for the decreased ex-
pression cannot be ruled out [7,9]. On the other
hand, the IFN-Q stimulation of B lymphocytes from
sham mice resulted in augmented NF-UB expression.
These changes in NF-UB expressions parallel the
changes in the potentiating of 26s proteasome activ-
ity. Involvement of IFN-Q in the regulation of pepti-
dase speci¢city of proteasomes is well known [41^43].
In the absence of IFN-Q, proteasome possesses only
the trypsin-like activity which is needed for MHCI I
peptide loading, whereas upon IFN-Q stimulation
proteasome is active in both trypsin-like and chymo-
trypsin-like activities essential for the destruction of
unwanted metabolic proteins. However, it remains
unknown whether presentation of antigenic peptides
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to MHCI I is also enhanced in B lymphocytes in
response to IFN-Q.
In summary, the present results indicate the poten-
tiating of 26s proteasomal activities in splenic lym-
phocytes following trauma-hemorrhage which corre-
lated with the activation of signal transduction in
CD3CD8 T lymphocytes and IFN-Q-stimulated B
lymphocytes, thus suggesting an important role for
proteasome in the regulation of lymphocyte func-
tions. Proteasomes are multi-catalytic and are in-
volved in both the activation and rapid removal of
regulatory proteins. Unlike lysosomal proteases or
other cytoplasmic proteases, the proteasomes are
possessed with the property of cleaving peptide
bonds at several distinct sites beside the three estab-
lished ones [41]. Furthermore, their catalytic func-
tions can be modulated by mediators of immune
function, e.g., IFN-Q [41^43] or protease inhibitors,
e.g., lactacystin [44]. These characteristics make pro-
teasomes a suitable candidate for therapeutic manip-
ulation to restitute immune depression, a major con-
sequence of trauma-hemorrhage.
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